Recently, the US Food and Drug Administration's (FDA) Center for Tobacco Products (CTP) awarded two grants to Dr. Tracy Smith at the Hollings Cancer Center at MUSC for researching the potential impact of allowing flavored e-cigarettes and banning the use of menthol.
This move has been welcomed by global tobacco harm reduction (THR) experts who have long urged the FDA to study the scientific basis of such products.
Smith said:
The FDA has the authority to do many things that can greatly assist in improving public health and reducing preventable diseases caused by smoking.
She will collaborate with Dr. Theodore Wagener, the director of the Tobacco Research Center at the Ohio State University Comprehensive Cancer Center, to conduct a $3.9 million research study on the flavors of electronic cigarettes.
Wagner stated that so far, any regulatory decisions made by the FDA have been based on incomplete scientific data.
He added that this would be the first study to provide the organization with authoritative information regarding whether the product is beneficial to adult smokers.
References:
A researcher at Hollings is examining the impact of menthol and e-cigarette flavors on current cigarette smokers.
This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.
